Generic drugs tend to be less expensive, as they don’t cost as much to develop. This is because brand-name medications are new drugs that require research, development, and clinical trials.

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

U.S. President Donald Trump on Sunday night said he will sign an executive order to reduce drug prices in the United States ...

US & Canada, May 09, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global Generic Drugs Market is growing owing to patent expiry and loss of ...

Generic drug substitution can markedly decrease the ... such as an allergic reaction to dye. If the development of such an effect requires stopping or changing medication, even temporarily ...

The Medical - Generic Drugs industry comprises companies that ... the company is focused on accelerating the development of its complex generics portfolio. RDY is also making efforts to ensure ...

In a major development in the long-running generics price-fixing litigation, the U.S. District Court for the District of ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

The generic medicine industry of India is unlikely to be impacted by United States president Donald Trump's decision to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General ...

Indian generic drugmakers typically operate on thin EBITDA margins of 5-15 percent on average for their base business in US, ...

Additionally, Cuban suggested that all pharmacies should be fully reimbursed for brand drugs and that the generic cost ratio ... It also directed the development of regulations aimed at reducing ...

Detailed price information for Amphastar Pharma (AMPH-Q) from The Globe and Mail including charting and trades.